Gradient Investments’s Sanofi SNY Stock Holding History

Gradient Investments’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,816	Closed	-$1.69M	–	429
2025 Q4	$1.69M	Buy	34,816 +12,436	+56%	+$616K	0.03%	222
2025 Q3	$1.06M	Buy	22,380 +10,025	+81%	+$484K	0.02%	256
2025 Q2	$597K	Buy	12,355 +2,591	+27%	+$132K	0.01%	278
2025 Q1	$542K	Buy	9,764 +200	+2%	+$10.8K	0.01%	235
2024 Q4	$461K	Buy	9,564 +184	+2%	+$9.36K	0.01%	236
2024 Q3	$541K	Sell	9,380 -207	-2%	-$11.2K	0.01%	220
2024 Q2	$465K	Buy	9,587 +95	+1%	+$4.58K	0.01%	246
2024 Q1	$461K	Buy	9,492 +9,075	+2,176%	+$443K	0.01%	234
2023 Q4	$20.7K	Hold	417	–	–	﹤0.01%	699
2023 Q3	$22.4K	Sell	417 -41	-9%	-$2.19K	﹤0.01%	659
2023 Q2	$24.7K	Buy	458 +53	+13%	+$2.85K	﹤0.01%	649
2023 Q1	$22K	Buy	405 +49	+14%	+$2.38K	﹤0.01%	662
2022 Q4	$17.2K	Sell	356 -10	-3%	-$439	﹤0.01%	715
2022 Q3	$14K	Sell	366 -8,281	-96%	-$369K	﹤0.01%	740
2022 Q2	$433K	Sell	8,647 -88	-1%	-$4.67K	0.01%	229
2022 Q1	$448K	Sell	8,735 -327	-4%	-$16.9K	0.01%	229
2021 Q4	$454K	Sell	9,062 -176	-2%	-$8.71K	0.01%	227
2021 Q3	$445K	Sell	9,238 -257	-3%	-$13.1K	0.01%	224
2021 Q2	$500K	Sell	9,495 -258	-3%	-$13.5K	0.01%	218
2021 Q1	$482K	Buy	+9,753	New	+$469K	0.02%	223
2020 Q3	–	Sell	-74	Closed	-$4K	–	1216
2020 Q2	$4K	Sell	74 -116	-61%	-$5.64K	﹤0.01%	794
2020 Q1	$8K	Buy	190 +153	+414%	+$7.32K	﹤0.01%	705
2019 Q4	$2K	Sell	37 -17	-31%	-$796	﹤0.01%	960
2019 Q3	$3K	Sell	54 -37,065	-100%	-$1.6M	﹤0.01%	889
2019 Q2	$1.61M	Buy	37,119 +10,691	+40%	+$455K	0.08%	147
2019 Q1	$1.17M	Sell	26,428 -17,578	-40%	-$753K	0.08%	115
2018 Q4	$1.91M	Sell	44,006 -13,320	-23%	-$587K	0.11%	100
2018 Q3	$2.56M	Buy	57,326 +8	+0%	+$342	0.13%	100
2018 Q2	$2.29M	Buy	57,318 +8,733	+18%	+$344K	0.12%	104
2018 Q1	$1.95M	Buy	48,585 +15,797	+48%	+$657K	0.11%	119
2017 Q4	$1.41M	Buy	32,788 +7,869	+32%	+$363K	0.08%	126
2017 Q3	$1.24M	Buy	24,919 +8,491	+52%	+$411K	0.08%	109
2017 Q2	$787K	Buy	16,428 +10,044	+157%	+$480K	0.06%	115
2017 Q1	$289K	Buy	6,384 +6,343	+15,471%	+$269K	0.02%	173
2016 Q4	$2K	Buy	+41	New	+$1.61K	﹤0.01%	636
2016 Q3	–	Sell	-100	Closed	-$4K	–	774
2016 Q2	$4K	Hold	100	–	–	﹤0.01%	561
2016 Q1	$4K	Buy	+100	New	+$4.02K	﹤0.01%	572
2014 Q2	–	Sell	-424	Closed	-$22K	–	562
2014 Q1	$22K	Buy	+424	New	+$21.5K	0.01%	278
2013 Q4	–	Sell	-50	Closed	-$3K	–	656
2013 Q3	$3K	Buy	+50	New	+$2.54K	﹤0.01%	386

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Gradient Investments's SNY Position: Q1 2026 in Review

Gradient Investments sold out of Sanofi (SNY) in Q1 2026, closing a stake of 34,816 shares — an estimated $1.69M sold.

Gradient Investments first reported a position in SNY in Q3 2013 and held it in 39 quarters. The position peaked at $2.56M in Q3 2018. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Gradient Investments reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Gradient Investments sold 34,816 Sanofi shares in Q1 2026, an estimated $1.69M.
Gradient Investments first reported a position in Sanofi in Q3 2013 and held it in 39 quarters.
Gradient Investments's Sanofi position peaked at $2.56M in Q3 2018.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Gradient Investments's 13F filing for Q1 2026, filed 13 Apr 2026.